Mount Sinai Researchers Streamline Patient Data to Find Patterns in COVID-19 Patients
With the influx of patient data resulting from the SARS-CoV-2 pandemic, the Mount Sinai COVID Informatics Center is collaborating with London-based software company Clinithink to uncover key findings that can enable better treatment methods for COVID-19 patients. Clinithink’s artificial intelligence platform, CLiX, …
Live Interview: Trellus Health Co-Founders Marla Dubinsky, MD and Laurie Keefer, PhD
Tune in to The Innovation Cafe, MSIP’s LinkedIn Live interview series, where Marla Dubinsky, MD and Laurie Keefer, PhD, of the Susan and Leonard Feinstein Inflammatory Bowel Disease (IBD) Clinical Center at Mount Sinai discussed how they developed Trellus Health – the …
Trellus Health Secures $5M Seed Funding to Transform Care for Chronic Conditions
Collaborates with Mount Sinai to deliver resilience-driven, connected care, integrating expert clinical and behavioral health for better outcomes Trellus Health, a resilience-driven digital health solution for chronic conditions, today announced that it has raised $5 million of seed funding to transform the way chronic …
Bio-Techne and Kantaro Biosciences to Launch a Quantitative Research Use Only COVID-19 Serology Test
Bio-Techne Corporation (NASDAQ:TECH) and the Mount Sinai Health System in New York, through its commercial affiliate Kantaro Biosciences LLC (Kantaro), today announced the anticipated launch of the COVID-SeroIndex, a Kantaro Quantitative SARS-CoV-2 IgG Antibody RUO kit. Bio-Techne and Kantaro will leverage a …
Mindful Care Training, a Clinical Education Platform for Domestic Abuse Survivors, wins the Mount Sinai Pitch Challenge 2020
Congratulations to Christina Blackburn, MS, who won the Mount Sinai Pitch Challenge in May for Mindful Care Training (MCT), a clinical education platform that offers support for domestic abuse survivors. The platform focuses on providing research-informed education in emergency and acute care …
Dynavax and Mount Sinai Announce Collaboration to Develop a Universal Influenza Vaccine Candidate with CpG 1018 Adjuvant
Development funded under contract award from NIAID/NIH as part of the CIVICs program Currently no approved universal influenza vaccine CDC estimates 35.5 million people were infected with influenza in U.S. during 2018-2019 season Collaboration will combine Dynavax’s CpG 1018 with influenza antigens designed to protect against …
Mount Sinai Health System and Renalytix Form Joint Venture, Kantaro Biosciences, To Develop and Scale Production of COVID Antibody Test Kits
Kantaro Biosciences partners with Bio-Techne for manufacturing and global kit distribution; Scaled kit production to enable clinical laboratories to conduct 10M tests per month is planned to begin in July Mount Sinai Health System (“Mount Sinai”) and RenalytixAI (LSE: RENX) today announced …
Mount Sinai’s Blood Test to Detect Antibodies to COVID-19 Receives Emergency Use Authorization From U.S. Food and Drug Administration
Today, the Mount Sinai Laboratory (MSL), Center for Clinical Laboratories received emergency use authorization from the U.S. Food and Drug Administration (FDA) for an antibody test that was developed, validated, and launched at Mount Sinai by a team of internationally renowned researchers …
Krishna J. Patel, PhD, is Awarded the Howard Bremer Scholarship by the Association of University Technology Managers
Krishna J. Patel, PhD, cRTTP, Business Development and Licensing Analyst of Mount Sinai Innovation Partners (MSIP), was awarded the Howard Bremer Scholarship through the Association of University Technology Managers (AUTM). The Scholarship honors emerging professionals bringing creativity and an innovative spirit to …